BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• 

  BioCapital

  Educational Institutions Highlight Biotech Through Partnerships and Programs

  Educational institutions, even at the high school level, are creating specialized biotechnology training programs to satisfy the growth they see within the biotech industry.

  May 22, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  uniQure, Bioverativ Unveil Positive Data for Hemophilia B and Hemophilia A Patients

  Hemophilia B patients have some good news to cheer. Data suggests that uniQure’s AAV5 gene therapy may be viable treatments for 97 percent of patients. However, uniQure wasn’t the only company touting positive news in the treatment of hemophilia.

  May 22, 2018

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Sesen Bio Shares Plunge Despite Reporting Positive Interim Phase III Results

  Shares of newly dubbed Sesen Bio (formerly Eleven Biotherapeutics) have plunged 23 percent after the company released positive, three-month data from its ongoing Phase III high-grade non-muscle invasive bladder cancer (NMIBC) trial.

  May 22, 2018

   · 

  2 min read

   · 

  Alex Keown
• Lonza Further Strengthens Hepatocytes Portfolio with Addition of Hepatic Non-Parenchymal Cells

  Lonza announced the addition of hepatic stellate cells, Kupffer cells and liver-derived endothelial cells to its extensive hepatocytes portfolio.

  May 22, 2018

   · 

  4 min read
• 

  Business

  Significant Bloc of AstraZeneca Shareholders Reject Executive Remuneration Plan

  AstraZeneca has a problem. Not with its pipeline, but with the way a significant chunk of shareholders views its executive pay program.

  May 22, 2018

   · 

  2 min read

   · 

  Alex Keown
• BioMidwest

  Model Estimates Lifetime Risk Of Alzheimer’s Dementia Using Biomarkers For Preclinical Disease

  Study finds lifetime risk of developing Alzheimer’s varies by age, gender; First estimates that include biomarkers.

  May 22, 2018

   · 

  5 min read
• Nobles Medical Technologies II Showcases Noblestitch™ PFO Closure At EuroPCR

  NOBLES MEDICAL TECHNOLOGIES II, INC. (NMT2) ANNOUNCES THE PRESENTATION OF ITS ITALIAN CLINICAL DATA PUBLISHED IN EUROINTERVENTION TO BE PRESENTED BY DR. FREDERICO DEMARCO

  May 22, 2018

   · 

  5 min read
• Kansai University research: Kansai University Medical Polymers

  Kansai University launches the Smart Materials for Advanced and Reliable Therapeutics (KU-SMART) Project.

  May 22, 2018

   · 

  3 min read
• Drug Development

  uniQure Presents New Data Demonstrating Clinical Benefit in Hemophilia B Patients with Pre-Existing Anti-AAV5 Neutralizing Antibodies

  uniQure N.V. presented data showing successful liver transduction with the AAV5 vector in both non-human primates and humans with pre-existing anti-AAV5 neutralizing antibodies (NABs).

  May 22, 2018

   · 

  6 min read
• Business

  Evotec and Celgene Enter into Strategic Oncology Partnership

  Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that Evotec and Celgene Corporation (“Celgene”) have entered into a long-term strategic drug discovery and development partnership to identify new therapeutics in oncology.

  May 22, 2018

   · 

  3 min read